top of page
2.png
background
profile picture

Welcome!  My name is Alper Karagöl (he/him).

I am a researcher in evolutionary structural biology. It is an area of biological structures (i.e Proteins, Lipids, DNA), focusing on how they evolved, and how they found their roles in disease presentations. Based in Istanbul and London, my research focuses on the evolution of neurotransmitter transporters, membrane receptors and beyond.​

I currently work as an intern Doctor med. (pre-registered physician) at Istanbul University Hospital. I conduct structural research with Shuguang Zhang at MIT and participate a genomic research collab with Darwin Building UCL (Steven J Perkins).

  • GitHub
  • LinkedIn
  • Instagram

Research Areas:​

Membrane Protein Structure and Function

  • Glutamate transporter stracture and dynamics

  • Co-evolution of alpha-helical membrane protein residues

  • Evolutionary adaptation to solvent environments

  • Lipid compositions related to olfactory neurons​

Karagöl et al. 2024a Pharm Res

Genomics and Genetics

  • Clinical Variant Databases, their  design and maintenance

  • mRNA alterations, ancient RNAs, RNA conservation 

  • Heamophilia Variants FIX, FVIII, Glutamate transporter gene architecture and splice altering variations

Karagöl et al. 2024 PLOS ONE

Protein-Protein Interactions and Self-Assembly

  • Neuronal proteins, their oligomers and dimers

  • Inhibitory truncated isoforms of transporters and membrane proteins

  • Isoform-based Tau-like self-assemblies

  • Water-soluble QTY-variants of membrane proteins​, neuronal proteins

  • MD simulations for membrane proteins, lipid distortions

  • MMGBSA, MMPBSA, and SVM predictions of binding affinity

Karagöl et al. 2024b Pharm Res

Computational Evolutionary Biology

  • Evolutionary residue analysis

  • Partial Spearman correlations and statistical modeling

  • Kernel causality and confounding variable partial correlations

  • Puryfiying selection, Shannon entropy, and evolutionary models

  • Genetic code structure and mutational pathways (e.g., V>A>T mutations)

  • Evolutionary Game Theory

  • Modeling evolutionary nodes in R​

Karagöl A & Karagöl T. 2024 bioarxiv

recent article: figure 3

Recent Updates:

Super excited to share our research paper on the inhibition of glutamate transporter oligomerization! 🎉 

Confused? Go to my twin's website >> www.tanerkaragol.com

The views and opinions expressed on this website are solely my own and do not reflect the views, policies, or positions of any institution, organization, or entity with which I am or have been affiliated.

Nothing on this website should be construed as professional, legal, or official advice. 

bottom of page